Liver transplantation for acute Budd-Chiari syndrome in identical twin sisters with factor V Leiden mutation

Transplantation

Volumn 76, Issue 1, 2003, Pages 195-198

  Nezakatgoo, Nosratollah ^a   Shokouh Amiri, M Hosein ^a   Gaber, A Osama ^a   Grewal, Hani P ^a   Vera, Santiago R ^a   Chamsuddin, Abbas A ^a   Eshun, John K ^b   Jeng, M ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; FLUOXETINE; IMMUNOSUPPRESSIVE AGENT; METHYLPHENIDATE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DNA DETERMINATION; EXERCISE INDUCED ASTHMA; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS; TREATMENT OUTCOME; TWINS;

EID: 0038299440     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000073977.83480.B1     Document Type: Article

References (12)

1. Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001; 48: 264.
2. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90: 1004.
3. Mambrini P, Mallet D, O'Callaghan T, et al. Budd-Chiari syndrome and activated protein C resistance. J Hepatol 1996; 24: 246.
4. Mahmoud AE, Elias E, Beauchamp N, et al. Prevalence of the FVL mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798.
5. Koster T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503.
6. Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in-patients homozygous for FVL (activated protein C resistance). Blood 1995; 85: 1504.
7. Tan HP, Markowitz JS, Maley WR, et al. Successful liver transplantation in a patient with BCS caused by homozygous FV Leiden. Liver Transpl 2000; 6: 654.
8. Avenhaus Ullerich H, Menzel J, Foerster EC, et al. Budd-Chiari syndrome in a patient with FVL - successful treatment by TIPSS placement followed by liver transplantation. Z Gastroenterol 1999; 37: 277.
9. Dahlback B, Hillarp A, Rosen S, et al. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis. Ann Hematol 1996; 72: 166.
10. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521.
11. Dahlback B. Procoagulant and anticoagulant properties of coagulation factor V: FV Leiden (APC resistance) causes hypercoagulability by dual mechanisms. J Lab Clin Med 1999; 133: 415.
12. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74: 415.